Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$59.65T
24h Vol:
$11.26B
Dominance:
MSFT:5.18%
Stocklytics Platform
BETA
Instrument logo  ELV

Elevance Health, Inc.

ELV
72 / 100
S&P500
$499.10arrow_drop_down-0.42%-$2.14

Performance History

Stocklytics logo
Key Stats
Open$499.62
Prev. Close$501.25
EPS25.21
Dividend$5.92
Next Earnings DateJun 24, 2024
Dividend Yield %1.30%
Market Cap$116.12B
PE Ratio19.80
LOWHIGH
Day Range492.06
500.48
52 Week Range412.00
516.60
Ratios
P/B Ratio2.97
Revenue$171.34B
Operating M. %5.64%
Earnings$5.99B
Earnings Growth %-0.47%
EBITDA Margin %6.39%
ROE %15.82%
EPS25.21

Score Breakdown

72vs 53. Market Avg.

All Score 72 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

ELVMARKET
Value3839
Quality6740
Ownership4019
Growth7046
Dividends3737
check_circle

Elevance Health, Inc.'s Price growth average in the last 3 years of 18.78% is great compared to market average of 7.45%. This indicates ELV could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$782.12
24H (%)arrow_drop_up3.77%
24H ($)$28.44
MARKET CAP$743.14B
PRICE$489.53
24H (%)arrow_drop_down-0.82%
24H ($)-$4.07
MARKET CAP$452.77B
PRICE$162.12
24H (%)arrow_drop_up0.45%
24H ($)$0.73
MARKET CAP$390.50B
PRICE$126.96
24H (%)arrow_drop_down-0.14%
24H ($)-$0.19
MARKET CAP$321.54B

About Elevance Health, Inc. (ELV)

Elevance Health, Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was founded in 1944 and is based in Indianapolis, Indiana.

Sector
Healthcare
Industry
Healthcare Plans
CEO
Ms. Gail Koziara Boudreaux
Headquarters
Indianapolis
Employees
102300
Exchange
NYSE
add Elevance Health, Inc. to watchlist

Keep an eye on Elevance Health, Inc.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is Elevance Health, Inc.'s (ELV) price per share?

The current price per share for Elevance Health, Inc. (ELV) is $499.11. The stock has seen a price change of -$2.14 recently, indicating a -0.43% change. This reflects the stock's recent market performance and investor sentiment.

question_mark
What is the 52-week high and low for Elevance Health, Inc. (ELV)?

For Elevance Health, Inc. (ELV), the 52-week high is $516.61, which is 3.51% from the current price. The 52-week low is $412, the current price is 21.14% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

question_mark
Is Elevance Health, Inc. (ELV) a growth stock?

Elevance Health, Inc. (ELV) has shown an average price growth of 18.57% over the past three years. It has received a score of 80 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Elevance Health, Inc. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

question_mark
What is Elevance Health, Inc. (ELV) stock price performance year to date (YTD)?

As of the latest data, Elevance Health, Inc. (ELV) has a year-to-date price change of 4.17%. Over the past month, the stock has experienced a price change of 0.77%. Over the last three months, the change has been 3.33%. Over the past six months, the figure is 10.84%. Looking at a longer horizon, the five-year price change stands at 70.58%.

question_mark
Is Elevance Health, Inc. (ELV) a profitable company?

Elevance Health, Inc. (ELV) has a net income of $5.99B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 89.91% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 5.64% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $171.34B, with a revenue growth rate of 9.42%, providing insight into the company's sales performance and growth. Operating income is noted at -$4M. Furthermore, the EBITDA is $10.95B.

question_mark
What is the market capitalization of Elevance Health, Inc. (ELV)?

Elevance Health, Inc. (ELV) has a market capitalization of $116.13B. The average daily trading volume is 922.73K, indicating the stock's liquidity and investor engagement.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.